Over 3k brands hit pharma mkt, cancer drug tops in sales

India's pharma market has introduced 3,151 new brands in the past year, with AstraZeneca's cancer drug Enhertu becoming the top-seller, reflecting a rise in cancer cases. Enhertu, exempted from customs duty, has significantly contributed to AstraZeneca's sales, highlighting the growing demand for innovative cancer treatments.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/DPHsTCw
via IFTTT